Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
84.45 EUR | +1.93% | +2.12% | +40.28% |
02/04 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
12/03 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.